Oral thin film formulations

The use of PVA, glycerol, and PEG in OTFs addresses brittleness and stickiness issues, providing a flexible, quickly dissolving oral thin film without thickeners or emulsifiers, suitable for diverse drug delivery needs.

GB2629820APending Publication Date: 2024-11-13FITABEO THERAPEUTICS LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
GB2023006966
Authority / Receiving Office
GB · GB
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-11
Publication Date
2024-11-13

AI Technical Summary

Technical Problem

Conventional oral thin films (OTFs) face issues such as brittleness, stickiness, and slow disintegration, which are particularly problematic for infants and geriatric patients, and often require thickeners and emulsifiers that can adversely affect disintegration.

Method used

A composition comprising polyvinyl alcohol (PVA) as a film-forming agent, glycerol, and polyethylene glycol (PEG) as plasticizers, with a combined weight ratio of 1:2.1 to 1:4, which provides improved elasticity, fast disintegration, and low stickiness without the need for thickeners and emulsifiers, and optionally includes hydroxypropyl methylcellulose (HPMC) or polyvinyl pyrrolidone (PVP) for enhanced properties.

Benefits of technology

The formulation achieves good elasticity, fast disintegration, and low stickiness, eliminating the need for thickeners and emulsifiers, making it suitable for pediatric and geriatric drug delivery, and can be adapted for various pharmaceutical applications.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A composition for an oral thin film, comprising: polyvinyl alcohol (PVA); glycerol; and polyethylene glycol (PEG); wherein the combined dry amount of glycerol and PEG is 12-24 wt.% and in a weight ratio of 1:2.1 to 1:4 respectively. The composition may comprise: 30-50 wt.% dry, or 10-18 wt.% wet, weight of PVA; 3-7 wt.% dry, or 1-6 wt.% wet, weight of glycerol; 3-17 wt.% dry, or 1.1-6.3 wt.% wet, weight of PEG. The composition may further comprise hydroxypropyl methylcellulose (HPMC) at 10-15 wt.% dry weight or 3.1-4.7 wt.% wet weight. The composition may not comprise a thickener or emulsifier. The composition may comprise a pharmaceutically acceptable solvent (e.g., water) at 60-95 wt.%. The composition may further comprise a salivary stimulant, sweetener, or flavouring agent; and a pharmaceutically active ingredient, such as an opioid. Also claimed is an orally dissolvable film comprising or made from the composition described. Also claimed is a method of preparing an orally dissolvable film, comprising casting on a support the composition. Also claimed is the defined composition or orally dissolvable film for use as a medicament. Also claimed is a composition for an oral thin film, comprising: hydroxypropyl methylcellulose; polyvinyl pyrrolidone (PVP); glycerol; and polyethylene glycol.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Oral instant film agent and preparation method thereof

    CN114886874A

  • Rapidly disintegrating oral film formulation for Olanzapin

    EP2486913A1

  • Non-mucoadhesive film dosage forms

    NZ575900A

  • Glycopyrrolate oral film and it's process

    WO2022023994A1